GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Affymax, Inc. (FRA:A5Y) » Definitions » YoY Rev. per Sh. Growth

Affymax, (FRA:A5Y) YoY Rev. per Sh. Growth : -90.91% (As of Jun. 2014)


View and export this data going back to . Start your Free Trial

What is Affymax, YoY Rev. per Sh. Growth?

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months. Affymax,'s YoY Rev. per Sh. Growth for the quarter that ended in Jun. 2014 was -90.91%.

Affymax,'s Revenue per Share for the three months ended in Jun. 2014 was €0.00.


Affymax, YoY Rev. per Sh. Growth Historical Data

The historical data trend for Affymax,'s YoY Rev. per Sh. Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Affymax, YoY Rev. per Sh. Growth Chart

Affymax, Annual Data
Trend Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13
YoY Rev. per Sh. Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.72 -16.85 -68.65 81.73 -98.64

Affymax, Quarterly Data
Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14
YoY Rev. per Sh. Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -81.97 -100.00 -100.00 -100.00 -90.91

Affymax, YoY Rev. per Sh. Growth Calculation

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months.

Affymax,'s YoY Rev. per Sh. Growth for the fiscal year that ended in Dec. 2013 is calculated as:

YoY Rev. per Sh. Growth (A: Dec. 2013 )
=(Revenue per Share (A: Dec. 2013 )-Revenue per Share (A: Dec. 2012 ))/ | Revenue per Share (A: Dec. 2012 ) |
=(0.027-1.979)/ | 1.979 |
=-98.64 %

Affymax,'s YoY Rev. per Sh. Growth for the quarter that ended in Jun. 2014 is calculated as:

YoY Rev. per Sh. Growth (Q: Jun. 2014 )
=(Revenue per Share (Q: Jun. 2014 )-Revenue per Share (Q: Jun. 2013 )) / | Revenue per Share (Q: Jun. 2013 )) |
=(0.001-0.011)/ | 0.011 |
=-90.91 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Affymax, YoY Rev. per Sh. Growth Related Terms

Thank you for viewing the detailed overview of Affymax,'s YoY Rev. per Sh. Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Affymax, (FRA:A5Y) Business Description

Traded in Other Exchanges
N/A
Address
630 Fifth Avenue, 2nd Floor, New York, NY, USA, 10020
Affymax Inc is a development-stage biopharmaceutical company, engaged in developing novel peptide-based therapeutics for the treatment of life-threatening conditions. The company's product includes OMONTYS, an injection for the treatment of anemia due to chronic kidney disease in adult patients on dialysis. OMONTYS is a synthetic, peptide-based erythropoiesis stimulating agent, or ESA, designed to stimulate the production of red blood cells and has been the only once-monthly ESA available to the adult dialysis patient population in the U.S.

Affymax, (FRA:A5Y) Headlines

No Headlines